Sökning: WFRF:(van der Knaap M S) > IDH2 Mutations in P...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 03290naa a2200553 4500 | |
001 | oai:gup.ub.gu.se/127444 | |
003 | SwePub | |
008 | 240910s2010 | |||||||||||000 ||eng| | |
024 | 7 | a https://gup.ub.gu.se/publication/1274442 URI |
024 | 7 | a https://doi.org/10.1126/science.11926322 DOI |
040 | a (SwePub)gu | |
041 | a eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Kranendijk, Martijn4 aut |
245 | 1 0 | a IDH2 Mutations in Patients with D-2-Hydroxyglutaric Aciduria. |
264 | 1 | b American Association for the Advancement of Science (AAAS),c 2010 |
520 | a Heterozygous somatic mutations in the genes encoding isocitrate dehydrogenase- 1 and -2 (IDH1 and IDH2) were recently discovered in human neoplastic disorders. These mutations disable the enzymes' normal ability to convert isocitrate to 2-ketoglutarate (2-KG) and confer on the enzymes a new function: the ability to convert 2-KG to d-2-hydroxyglutarate (D-2-HG). We have detected heterozygous germline mutations in IDH2 that alter enzyme residue R140 in 15 unrelated patients with d-2-hydroxyglutaric aciduria (D-2-HGA), a rare neurometabolic disorder characterized by supraphysiological levels of D-2-HG. These findings provide additional impetus for investigating the role of D-2-HG in the pathophysiology of metabolic disease and cancer. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Medicinsk bioteknologix Medicinsk bioteknologi0 (SwePub)304012 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Medical Biotechnologyx Medical Biotechnology0 (SwePub)304012 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Annan klinisk medicin0 (SwePub)302992 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Other Clinical Medicine0 (SwePub)302992 hsv//eng |
700 | 1 | a Struys, Eduard A4 aut |
700 | 1 | a van Schaftingen, Emile4 aut |
700 | 1 | a Gibson, K Michael4 aut |
700 | 1 | a Kanhai, Warsha A4 aut |
700 | 1 | a van der Knaap, Marjo S4 aut |
700 | 1 | a Amiel, Jeanne4 aut |
700 | 1 | a Buist, Neil R4 aut |
700 | 1 | a Das, Anibh M4 aut |
700 | 1 | a de Klerk, Johannis B4 aut |
700 | 1 | a Feigenbaum, Annette S4 aut |
700 | 1 | a Grange, Dorothy K4 aut |
700 | 1 | a Hofstede, Floris C4 aut |
700 | 1 | a Holme, Elisabeth,d 1947u Gothenburg University,Göteborgs universitet,Institutionen för biomedicin, avdelningen för klinisk kemi och transfusionsmedicin,Institute of Biomedicine, Department of Clinical Chemistry and Transfusion Medicine4 aut0 (Swepub:gu)xholme |
700 | 1 | a Kirk, Edwin P4 aut |
700 | 1 | a Korman, Stanley H4 aut |
700 | 1 | a Morava, Eva4 aut |
700 | 1 | a Morris, Andrew4 aut |
700 | 1 | a Smeitink, Jan4 aut |
700 | 1 | a Sukhai, Rám N4 aut |
700 | 1 | a Vallance, Hilary4 aut |
700 | 1 | a Jakobs, Cornelis4 aut |
700 | 1 | a Salomons, Gajja S4 aut |
710 | 2 | a Göteborgs universitetb Institutionen för biomedicin, avdelningen för klinisk kemi och transfusionsmedicin4 org |
773 | 0 | t Science (New York, N.Y.)d : American Association for the Advancement of Science (AAAS)g 330:6002q 330:6002x 1095-9203x 0036-8075 |
856 | 4 8 | u https://gup.ub.gu.se/publication/127444 |
856 | 4 8 | u https://doi.org/10.1126/science.1192632 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy